262 related articles for article (PubMed ID: 35307892)
21. Altered MicroRNA Expression Is Associated with Tumor Grade, Molecular Background and Outcome in Childhood Infratentorial Ependymoma.
Zakrzewska M; Fendler W; Zakrzewski K; Sikorska B; Grajkowska W; Dembowska-Bagińska B; Filipek I; Stefańczyk Ł; Liberski PP
PLoS One; 2016; 11(7):e0158464. PubMed ID: 27390862
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment.
Witt H; Gramatzki D; Hentschel B; Pajtler KW; Felsberg J; Schackert G; Löffler M; Capper D; Sahm F; Sill M; von Deimling A; Kool M; Herrlinger U; Westphal M; Pietsch T; Reifenberger G; Pfister SM; Tonn JC; Weller M;
Neuro Oncol; 2018 Nov; 20(12):1616-1624. PubMed ID: 30053291
[TBL] [Abstract][Full Text] [Related]
23. Ependymoma: Evaluation and Management Updates.
Rudà R; Bruno F; Pellerino A; Soffietti R
Curr Oncol Rep; 2022 Aug; 24(8):985-993. PubMed ID: 35384591
[TBL] [Abstract][Full Text] [Related]
24. Adult intracranial ependymoma-relevance of DNA methylation profiling for diagnosis, prognosis, and treatment.
Träger M; Schweizer L; Pérez E; Schmid S; Hain EG; Dittmayer C; Onken J; Fukuoka K; Ichimura K; Schüller U; Dührsen L; Müther M; Paulus W; Thomas C; Gutt-Will M; Schucht P; Maragkou T; Schittenhelm J; Eckert F; Niyazi M; Fleischmann DF; Dorostkar MM; Feyer P; May SA; Moskopp D; Badakhshi H; Radke C; Walter J; Ehret F; Capper D; Kaul D
Neuro Oncol; 2023 Jul; 25(7):1286-1298. PubMed ID: 36734226
[TBL] [Abstract][Full Text] [Related]
25. The transcription factor evi-1 is overexpressed, promotes proliferation, and is prognostically unfavorable in infratentorial ependymomas.
Koos B; Bender S; Witt H; Mertsch S; Felsberg J; Beschorner R; Korshunov A; Riesmeier B; Pfister S; Paulus W; Hasselblatt M
Clin Cancer Res; 2011 Jun; 17(11):3631-7. PubMed ID: 21493867
[TBL] [Abstract][Full Text] [Related]
26. Molecular heterogeneity and CXorf67 alterations in posterior fossa group A (PFA) ependymomas.
Pajtler KW; Wen J; Sill M; Lin T; Orisme W; Tang B; Hübner JM; Ramaswamy V; Jia S; Dalton JD; Haupfear K; Rogers HA; Punchihewa C; Lee R; Easton J; Wu G; Ritzmann TA; Chapman R; Chavez L; Boop FA; Klimo P; Sabin ND; Ogg R; Mack SC; Freibaum BD; Kim HJ; Witt H; Jones DTW; Vo B; Gajjar A; Pounds S; Onar-Thomas A; Roussel MF; Zhang J; Taylor JP; Merchant TE; Grundy R; Tatevossian RG; Taylor MD; Pfister SM; Korshunov A; Kool M; Ellison DW
Acta Neuropathol; 2018 Aug; 136(2):211-226. PubMed ID: 29909548
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of the histological and molecular characteristics of ependymal tumors: a single institution case series from China.
Xi S; Sai K; Hu W; Wang F; Chen Y; Wang J; Zeng J; Chen Z
BMC Cancer; 2019 Jul; 19(1):717. PubMed ID: 31324163
[TBL] [Abstract][Full Text] [Related]
28. Implications of DNA Methylation Classification in Diagnosing Ependymoma.
Abe E; Suzuki M; Ichimura K; Arakawa A; Satomi K; Ogino I; Hara T; Iwamuro H; Ohara Y; Kondo A
World Neurosurg; 2024 May; 185():e1019-e1029. PubMed ID: 38479644
[TBL] [Abstract][Full Text] [Related]
29. Merlin expression in pediatric anaplastic ependymomas real time PCR study.
Buccoliero AM; Castiglione F; Rossi Degl'Innocenti D; Sardi I; Genitori L; Taddei GL
Fetal Pediatr Pathol; 2010; 29(4):245-54. PubMed ID: 20594149
[TBL] [Abstract][Full Text] [Related]
30. Biology and management of ependymomas.
Wu J; Armstrong TS; Gilbert MR
Neuro Oncol; 2016 Jul; 18(7):902-13. PubMed ID: 27022130
[TBL] [Abstract][Full Text] [Related]
31. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
[TBL] [Abstract][Full Text] [Related]
32. Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutation.
Neyazi S; Yamazawa E; Hack K; Tanaka S; Nagae G; Kresbach C; Umeda T; Eckhardt A; Tatsuno K; Pohl L; Hana T; Bockmayr M; Kim P; Dorostkar MM; Takami T; Obrecht D; Takai K; Suwala AK; Komori T; Godbole S; Wefers AK; Otani R; Neumann JE; Higuchi F; Schweizer L; Nakanishi Y; Monoranu CM; Takami H; Engertsberger L; Yamada K; Ruf V; Nomura M; Mohme T; Mukasa A; Herms J; Takayanagi S; Mynarek M; Matsuura R; Lamszus K; Ishii K; Kluwe L; Imai H; von Deimling A; Koike T; Benesch M; Kushihara Y; Snuderl M; Nambu S; Frank S; Omura T; Hagel C; Kugasawa K; Mautner VF; Ichimura K; Rutkowski S; Aburatani H; Saito N; Schüller U
Acta Neuropathol; 2024 Jan; 147(1):22. PubMed ID: 38265489
[TBL] [Abstract][Full Text] [Related]
33. EZHIP: a new piece of the puzzle towards understanding pediatric posterior fossa ependymoma.
Jenseit A; Camgöz A; Pfister SM; Kool M
Acta Neuropathol; 2022 Jan; 143(1):1-13. PubMed ID: 34762160
[TBL] [Abstract][Full Text] [Related]
34. Chromosomal imbalances in clear cell ependymomas.
Rickert CH; Korshunov A; Paulus W
Mod Pathol; 2006 Jul; 19(7):958-62. PubMed ID: 16648869
[TBL] [Abstract][Full Text] [Related]
35. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1.
Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T
Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953
[TBL] [Abstract][Full Text] [Related]
36. Region Specific Differences of Claudin-5 Expression in Pediatric Intracranial Ependymomas: Potential Prognostic Role in Supratentorial Cases.
Virág J; Haberler C; Baksa G; Piurkó V; Hegedüs Z; Reiniger L; Bálint K; Chocholous M; Kiss A; Lotz G; Glasz T; Schaff Z; Garami M; Hegedűs B
Pathol Oncol Res; 2017 Apr; 23(2):245-252. PubMed ID: 27395057
[TBL] [Abstract][Full Text] [Related]
37. Ependymomas in Children and Adults.
Lampros M; Vlachos N; Alexiou GA
Adv Exp Med Biol; 2023; 1405():99-116. PubMed ID: 37452936
[TBL] [Abstract][Full Text] [Related]
38. Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome.
Jünger ST; Andreiuolo F; Mynarek M; Dörner E; Zur Mühlen A; Rutkowski S; von Bueren AO; Pietsch T
Childs Nerv Syst; 2020 Nov; 36(11):2693-2700. PubMed ID: 32474813
[TBL] [Abstract][Full Text] [Related]
39. Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma.
Tomomasa R; Arai Y; Kawabata-Iwakawa R; Fukuoka K; Nakano Y; Hama N; Nakata S; Suzuki N; Ishi Y; Tanaka S; Takahashi JA; Yuba Y; Shiota M; Natsume A; Kurimoto M; Shiba Y; Aoki M; Nabeshima K; Enomoto T; Inoue T; Fujimura J; Kondo A; Yao T; Okura N; Hirose T; Sasaki A; Nishiyama M; Ichimura K; Shibata T; Hirato J; Yokoo H; Nobusawa S
Brain Pathol; 2021 May; 31(3):e12943. PubMed ID: 33576087
[TBL] [Abstract][Full Text] [Related]
40. ZFTA-YAP1 fusion-positive ependymoma can occur in the spinal cord: Letter to the editor.
Lim KY; Lee KH; Phi JH; Yun H; Won JK; Choi SH; Park SH
Brain Pathol; 2022 Jan; 32(1):e13020. PubMed ID: 34506076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
